XORTX Therapeutics Inc (XRTX)
NASDAQ: XRTX · IEX Real-Time Price · USD
1.32
-0.08 (-5.71%)
At close: May 20, 2022 4:00 PM
1.34
0.02 (1.52%)
After-hours:May 20, 2022 4:00 PM EDT
Income Statement (Quarterly)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Quarter Ended | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 |
|---|---|---|---|---|---|---|---|---|
| Selling, General & Admin | 0.71 | 0.59 | 0.25 | 0.16 | 0.28 | 0.21 | 0.11 | 0.11 |
| Research & Development | 2.44 | 0.43 | 0.38 | 0.03 | 0.01 | 0.14 | 0.12 | 0.01 |
| Other Operating Expenses | 0.49 | 0.59 | -0.23 | 0.68 | 0.47 | 0.1 | 0.15 | 0.25 |
| Operating Expenses | 3.64 | 1.61 | 0.4 | 0.87 | 0.77 | 0.44 | 0.38 | 0.37 |
| Operating Income | -3.64 | -1.61 | -0.4 | -0.87 | -0.77 | -0.44 | -0.38 | -0.37 |
| Interest Expense / Income | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Expense / Income | -0.21 | -10.7 | 7.95 | -0.65 | 1.4 | 0.01 | 0.04 | -0 |
| Pretax Income | -3.42 | 9.09 | -8.35 | -0.22 | -2.17 | -0.45 | -0.42 | -0.37 |
| Net Income | -3.42 | 9.09 | -8.35 | -0.22 | -2.17 | -0.45 | -0.42 | -0.37 |
| Net Income Common | -3.42 | 9.09 | -8.35 | -0.22 | -2.17 | -0.45 | -0.42 | -0.37 |
| Shares Outstanding (Basic) | 13 | 10 | 9 | 9 | 8 | 7 | 7 | 7 |
| Shares Outstanding (Diluted) | 13 | 10 | 9 | 9 | 8 | 7 | 7 | 7 |
| Shares Change | 57.76% | 42.38% | 35.96% | 35.60% | - | - | - | - |
| EPS (Basic) | -0.26 | 1.02 | -0.89 | -0.02 | -0.26 | -0.06 | -0.06 | -0.05 |
| EPS (Diluted) | -0.26 | 1.02 | -0.89 | -0.02 | -0.26 | -0.06 | -0.06 | -0.05 |
| Free Cash Flow Per Share | -0.24 | -0.40 | -0.01 | - | -0.14 | 0.23 | -0.02 | - |
| EBITDA | -3.42 | 9.1 | -8.35 | - | -2.17 | -0.45 | -0.42 | - |
| EBIT | -3.43 | 9.1 | -8.35 | -0.22 | -2.17 | -0.45 | -0.42 | -0.37 |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).